Prostate Cancer Awareness Month

home / awareness-month / sept-2023-prostate-cancer-awareness-month

Prostate Cancer Awareness Month, which takes place in September, celebrates the progress within prostate cancer while addressing pivotal and ongoing research efforts. On this page, CancerNetwork highlights insights from key prostate cancer experts in article, video, and podcast formats on the evolving trends in the field.

Artificial Intelligence May Improve Detection, Prostate Cancer Decision Making | Image Credit: © Dr_Microbe - stock.adobe.com.

Artificial Intelligence May Improve Detection, Prostate Cancer Decision Making

Hayley Virgil
September 14th 2023

Across several clinical trials, Unfold AI appears to help in prostate cancer treatment selection and follow-up.

Artificial intelligence may be useful in screening for prostate cancer in patients with elevated prostate specific antigen levels who have undergone MRI, according to Wayne G. Brisbane, MD.

AI May Help With MRI Interpretation During Prostate Cancer Detection

Wayne G. Brisbane, MD
September 24th 2023

Artificial intelligence may be useful in screening for prostate cancer in patients with elevated prostate specific antigen levels who have undergone MRI, according to Wayne G. Brisbane, MD.

An artificial intelligence algorithm appears to create accurate focal treatment margins in patients with prostate cancer, according to Wayne G. Brisbane, MD.

Selecting Patients Best Suited for AI Prostate Cancer Detection

Wayne G. Brisbane, MD
September 25th 2023

An artificial intelligence algorithm appears to create accurate focal treatment margins in patients with prostate cancer, according to Wayne G. Brisbane, MD.

Artificial intelligence may help detect tumors both within the prostate and that have spread to areas outside of the prostate, according to Wayne G. Brisbane, MD.

Imaging, Patient Demographics May Inform AI Learning in Prostate Cancer

Wayne G. Brisbane, MD
September 26th 2023

Artificial intelligence may help detect tumors both within the prostate and that have spread to areas outside of the prostate, according to Wayne G. Brisbane, MD.

Artificial intelligence programs may help introduce new care strategies that minimize the risk of adverse effects in patients with prostate cancer, according to Wayne G. Brisbane, MD.

AI May Assist in Prostate Cancer Diagnosis, Risk Stratification, and Treatment

Wayne G. Brisbane, MD
September 27th 2023

Artificial intelligence programs may help introduce new care strategies that minimize the risk of adverse effects in patients with prostate cancer, according to Wayne G. Brisbane, MD.

Neeraj Agarwal, MD, states that he is optimistic about the development of new treatment options including immunotherapies, CAR T-cell therapies, and antibody-drug conjugates for metastatic prostate cancer.

Novel Drugs May Introduce ‘New Era’ of Metastatic Prostate Cancer Treatment

Russ Conroy
September 30th 2023

Neeraj Agarwal, MD, states that he is optimistic about the development of new treatment options including immunotherapies, CAR T-cell therapies, and antibody-drug conjugates for metastatic prostate cancer.

Germline testing may elucidate important mutations in patients with metastatic prostate cancer who may be eligible to receive treatment with PARP inhibitors, according to Neeraj Agarwal, MD.

Genomic Testing Cannot be ‘Ignored’ in Metastatic Prostate Cancer

Neeraj Agarwal, MD
October 16th 2023

Germline testing may elucidate important mutations in patients with metastatic prostate cancer who may be eligible to receive treatment with PARP inhibitors, according to Neeraj Agarwal, MD.